Literature DB >> 20584844

Review of haemophagocytic lymphohistiocytosis.

H R Freeman1, A V Ramanan.   

Abstract

Haemophagocytic lymphohistiocytosis (HLH) describes a clinical syndrome of hyperinflammation resulting in an uncontrolled and ineffective immune response. It may develop subsequent to a number of recognised genetic mutations or in association with infection, malignancy, autoinflammatory or metabolic conditions. Even with the published diagnostic criteria it can be difficult to make the diagnosis of HLH. Patients presenting acutely to the general paediatrician or paediatric intensivist with a clinical picture of likely sepsis, ie fever, laboratory evidence of inflammatory response, coagulopathy and thrombocytopaenia should be appropriately investigated and managed for sepsis, but the possible diagnosis of HLH should be borne in mind, particularly in the child who deteriorates despite maximal therapy. This review discusses current knowledge on the classification, diagnosis and management of primary and secondary HLH, and suggests a pathway of investigation for the paediatrician faced with a potential case.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584844     DOI: 10.1136/adc.2009.176610

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  34 in total

1.  Cytomegalovirus associated haemophagocytic lymphohistiocytosis in the immunocompetent adult managed according to HLH-2004 diagnostic using clinical and serological means only.

Authors:  M Atim-Oluk
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03-13

2.  Macrophage activation syndrome in a newborn infant born to a mother with autoimmune disease.

Authors:  J H Park; S H Kim; H J Kim; S J Lee; D C Jeong; S Y Kim
Journal:  J Perinatol       Date:  2015-02       Impact factor: 2.521

3.  Putting Schemas to the Test: An Exercise in Clinical Reasoning.

Authors:  Daniel J Minter; Reza Manesh; Patricia Cornett; Rabih M Geha
Journal:  J Gen Intern Med       Date:  2018-07-31       Impact factor: 5.128

4.  Haemophagocytic lymphohistiocytosis complicating visceral leishmaniasis in the UK: a case for detailed travel history, a high index of suspicion and timely diagnostics.

Authors:  Sarah May Johnson; Kimberly Gilmour; Sujith Samarasinghe; Alasdair Bamford
Journal:  BMJ Case Rep       Date:  2019-07-10

5.  Hemophagocytic Lymphohistiocytosis: A Confusing Problem of the Diagnosis of Visceral Leishmaniasis.

Authors:  Nese Yarali; Sadan Hacisalihoglu; Vildan Culha; Orcan Altan; Dilek Gurlek Gokcebay
Journal:  Indian J Hematol Blood Transfus       Date:  2017-06-09       Impact factor: 0.900

6.  An unusual cause of limp.

Authors:  Mehdi Garbash; Vidhooshni Rajamoorthy; Shrinavas Tambe; John Schofield; Nikila Pandya
Journal:  BMJ Case Rep       Date:  2012-04-04

7.  An uncommon presentation of EBV-driven HLH. Primary or secondary? An ongoing dilemma.

Authors:  Tânia Serrão; Alexandra Dias; Pedro Nunes; António Figueiredo
Journal:  BMJ Case Rep       Date:  2015-05-06

8.  Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma.

Authors:  Dylan E Lee; M Estela Martinez-Escala; Linda M Serrano; Xiaolong A Zhou; Jason B Kaplan; Barbara Pro; Jaehyuk Choi; Joan Guitart
Journal:  JAMA Dermatol       Date:  2018-07-01       Impact factor: 10.282

9.  Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis in late adulthood.

Authors:  Guilherme Grossi Lopes Cançado; Guilherme Gomes Freitas; Flavia Helena Fidelis Faria; Antonio Vaz de Macedo; Vandack Nobre
Journal:  Am J Trop Med Hyg       Date:  2013-01-16       Impact factor: 2.345

10.  Scrub typhus associated with hemophagocytic lymphohistiocytosis: A report of six pediatric patients.

Authors:  Yingkang Jin; Li Huang; Huifeng Fan; Gen Lu; Yi Xu; Zhiyuan Wu
Journal:  Exp Ther Med       Date:  2016-09-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.